Home > Back to Publisher > Report Information

South and Central America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Global Markets Direct
September 28, 2009
64 Pages - SKU: GMD2469451

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Central America, South America

South and Central America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to South & Central America drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in South & Central America.

Scope

The report provides information on the drug delivery devices market in South & Central America.
Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
Total revenues, products sold and end users.
Market shares of all the key competitors such as GlaxoSmithKline plc, AstraZeneca International plc, Boehringer Ingelheim GmbH, Novartis AG, and Baxter International Inc.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.

Reasons to buy

Gain a strong understanding of the drug delivery devices market in South and Central America.
Evaluate and compare the attractiveness of the market in the region.
Identify growth segments and opportunities in each industry sector within the region.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
Analyze the competitiveness of the market in the region and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the region.
Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
Identify and analyze the strengths and weaknesses of the industry incumbents in the region.

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report: 3.1 Drug Delivery Devices; 3.2 Inhalation Systems; 3.3 Infusion Systems
4 Drug Delivery Devices in South and Central America: 4.1 Drug Delivery Devices, South and Central America, Overall Revenue ($ mn), 2000-2015; 4.2 Drug Delivery Devices, South and Central America, Category Volume (Units), 2000-2015; 4.3 Drug Delivery Devices, South and Central America, Company share (2007-2008)
5 Drug Delivery Devices In Argentina: 5.1 Drug Delivery Devices, Argentina, Overall Revenue ($ mn), 2000-2015; 5.2 Drug Delivery Devices, Argentina, Category Volume (Units), 2000-2015; 5.3 Drug Delivery Devices, Argentina, Distribution Share (2007-2008); 5.4 Drug Delivery Devices, Argentina, Company Share (2007-2008)
6 Drug Delivery Devices In Brazil: 6.1 Drug Delivery Devices, Brazil, Overall Revenue ($ mn), 2000-2015; 6.2 Drug Delivery Devices, Brazil, Category Volume (Units), 2000-2015; 6.3 Drug Delivery Devices, Brazil, Distribution Share (2007-2008); 6.4 Drug Delivery Devices, Brazil, Company Share (2007-2008)
7 Drug Delivery Devices In Mexico: 7.1 Drug Delivery Devices, Mexico, Overall Revenue ($ mn), 2000-2015; 7.2 Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2015; 7.3 Drug Delivery Devices, Mexico, Distribution Share (2007-2008); 7.4 Drug Delivery Devices, Mexico, Company Share (2007-2008)
8 Overview of Key Companies in South and Central America Drug Delivery Devices Market: 8.1 Terumo Corporation; 8.2 Smiths Medical; 8.3 Novartis AG; 8.4 NIPRO CORPORATION; 8.5 GlaxoSmithKline plc; 8.6 Boehringer Ingelheim GmbH; 8.7 Consort Medical plc; 8.8 Baxter International Inc.; 8.9 AstraZeneca PLC; 8.10 Cardinal Health, Inc.; 8.11 B. Braun Melsungen AG; 8.12 Hospira, Inc.; 8.13 Fresenius Kabi AG
9 Appendix: 9.1 Global Markets Direct Research Methodology; 9.2 Secondary Research; 9.3 Primary Research; 9.4 Models; 9.5 Forecasts; 9.6 Expert Panel Validation; 9.7 Currency Conversion; 9.8 Contact Us; 9.9 Disclaimer
1.1 List of Tables: Table 1: Drug Delivery Devices, South and Central America, Overall Revenue ($ mn), 2000-2015; Table 2: Drug Delivery Devices, South and Central America, Cross-Category Analysis, 2000-2015; Table 3: Drug Delivery Devices, South and Central America, Overall Revenue ($ mn), Historic, 2000-2008; Table 4: Drug Delivery Devices, South and Central America, Overall Revenue ($ mn), Forecast, 2008-2015; Table 5: Drug Delivery Devices, South and Central America, Category Volume (Units), 2000-2015; Table 6: Drug Delivery Devices, South and Central America, Category Volume (Units), Historic, 2000-2008; Table 7: Drug Delivery Devices, South and Central America, Category Volume (Units), Forecast, 2008-2015; Table 8: Drug Delivery Devices, South and Central America, Company share by Revenue ($ mn), 2007-2008; Table 9: Drug Delivery Devices, Argentina, Overall Revenue ($ mn), 2000-2015; Table 10: Drug Delivery Devices, Argentina, Overall Revenue ($ mn), Historic, 2000-2008; Table 11: Drug Delivery Devices, Argentina, Overall Revenue ($ mn), Forecast, 2008-2015; Table 12: Drug Delivery Devices, Argentina, Category Volume (Units), 2000-2015; Table 13: Drug Delivery Devices, Argentina, Category Volume (Units), Historic, 2000-2008; Table 14: Drug Delivery Devices, Argentina, Category Volume (Units), Forecast, 2008-2015; Table 15: Infusion Systems, Argentina, Distribution Share by Revenue ($mn), 2007-2008; Table 16: Inhalation Systems, Argentina, Distribution Share by Revenue ($mn), 2007-2008; Table 17: Drug Delivery Devices, Argentina, Company Share by Revenue ($ mn), 2007-2008; Table 18: Infusion Systems, Argentina, Company Share by Revenue ($ mn), 2007-2008; Table 19: Inhalation Systems, Argentina, Company Share by Revenue ($ mn), 2007-2008; Table 20: Drug Delivery Devices, Brazil, Overall Revenue ($ mn), 2000-2015; Table 21: Drug Delivery Devices, Brazil, Overall Revenue ($ mn), Historic, 2000-2008; Table 22: Drug Delivery Devices, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015; Table 23: Drug Delivery Devices, Brazil, Category Volume (Units), 2000-2015; Table 24: Drug Delivery Devices, Brazil, Category Volume (Units), Historic, 2000-2008; Table 25: Drug Delivery Devices, Brazil, Category Volume (Units), Forecast, 2008-2015; Table 26: Infusion Systems, Brazil, Distribution Share by Revenue ($mn), 2007-2008; Table 27: Inhalation Systems, Brazil, Distribution Share by Revenue ($mn), 2007-2008; Table 28: Drug Delivery Devices, Brazil, Company Share by Revenue ($ mn), 2007-2008; Table 29: Infusion Systems, Brazil, Company Share by Revenue ($ mn), 2007-2008; Table 30: Inhalation Systems, Brazil, Company Share by Revenue ($ mn), 2007-2008; Table 31: Drug Delivery Devices, Mexico, Overall Revenue ($ mn), 2000-2015; Table 32: Drug Delivery Devices, Mexico, Overall Revenue ($ mn), Historic, 2000-2008; Table 33: Drug Delivery Devices, Mexico, Overall Revenue ($ mn), Forecast, 2008-2015; Table 34: Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2015; Table 35: Drug Delivery Devices, Mexico, Category Volume (Units), Historic, 2000-2008; Table 36: Drug Delivery Devices, Mexico, Category Volume (Units), Forecast, 2008-2015; Table 37: Infusion Systems, Mexico, Distribution Share by Revenue ($mn), 2007-2008; Table 38: Inhalation Systems, Mexico, Distribution Share by Revenue ($mn), 2007-2008; Table 39: Drug Delivery Devices, Mexico, Company Share by Revenue ($ mn), 2007-2008; Table 40: Infusion Systems, Mexico, Company Share by Revenue ($ mn), 2007-2008; Table 41: Inhalation Systems, Mexico, Company Share by Revenue ($ mn), 2007-2008; Table 42: NIPRO CORPORATION Pipeline Products by Equipment Type; Table 43: NIPRO CORPORATION Pipeline Products By Development Stage; Table 44: NIPRO CORPORATION Pipeline Products By Therapy Area; Table 45: Bespak plc Pipeline Products by Equipment Type; Table 46: Bespak plc Pipeline Products By Development Stage; Table 47: Bespak plc Pipeline Products By Therapy Area; Table 48: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures: Figure 1 Drug Delivery Devices, South and Central America, Overall Revenue ($ mn), 2000-2015; Figure 2: Drug Delivery Devices, South and Central America, Cross-Category Analysis, 2000-2015; Figure 3 Drug Delivery Devices, South and Central America, Overall Revenue ($ mn), Historic, 2000-2008; Figure 4 Drug Delivery Devices, South and Central America, Overall Revenue ($ mn), Forecast, 2008-2015; Figure 5 Drug Delivery Devices, South and Central America, Category Volume (Units), 2000-2015; Figure 6 Drug Delivery Devices, South and Central America, Category Volume (Units), Historic, 2000-2008; Figure 7 Drug Delivery Devices, South and Central America, Category Volume (Units), Forecast, 2008-2015; Figure 8 Drug Delivery Devices, South and Central America, Company share (%), 2008; Figure 9 Drug Delivery Devices, Argentina, Overall Revenue ($ mn), 2000-2015; Figure 10 Drug Delivery Devices, Argentina, Overall Revenue ($ mn), Historic, 2000-2008; Figure 11 Drug Delivery Devices, Argentina, Overall Revenue ($ mn), Forecast, 2008-2015; Figure 12 Drug Delivery Devices, Argentina, Category Volume (Units), 2000-2015; Figure 13 Drug Delivery Devices, Argentina, Category Volume (Units), Historic, 2000-2008; Figure 14 Drug Delivery Devices, Argentina, Category Volume (Units), Forecast, 2008-2015; Figure 15 Drug Delivery Devices, Argentina, Company Share (%), 2008; Figure 16 Infusion Systems, Argentina, Company Share (%), 2008; Figure 17 Inhalation Systems, Argentina, Company Share (%), 2008; Figure 18 Drug Delivery Devices, Brazil, Overall Revenue ($ mn), 2000-2015; Figure 19 Drug Delivery Devices, Brazil, Overall Revenue ($ mn), Historic, 2000-2008; Figure 20 Drug Delivery Devices, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015; Figure 21 Drug Delivery Devices, Brazil, Category Volume (Units), 2000-2015; Figure 22 Drug Delivery Devices, Brazil, Category Volume (Units), Historic, 2000-2008; Figure 23 Drug Delivery Devices, Brazil, Category Volume (Units), Forecast, 2008-2015; Figure 24 Drug Delivery Devices, Brazil, Company Share (%), 2008; Figure 25 Infusion Systems, Brazil, Company Share (%), 2008; Figure 26 Inhalation Systems, Brazil, Company Share (%), 2008; Figure 27 Drug Delivery Devices, Mexico, Overall Revenue ($ mn), 2000-2015; Figure 28 Drug Delivery Devices, Mexico, Overall Revenue ($ mn), Historic, 2000-2008; Figure 29 Drug Delivery Devices, Mexico, Overall Revenue ($ mn), Forecast, 2008-2015; Figure 30 Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2015; Figure 31 Drug Delivery Devices, Mexico, Category Volume (Units), Historic, 2000-2008; Figure 32 Drug Delivery Devices, Mexico, Category Volume (Units), Forecast, 2008-2015; Figure 33 Drug Delivery Devices, Mexico, Company Share (%), 2008; Figure 34 Infusion Systems, Mexico, Company Share (%), 2008; Figure 35 Inhalation Systems, Mexico, Company Share (%), 2008; Figure 36 Global Markets Direct Methodology

More South America Drug Delivery Reports

Chile Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017 by Global Markets Direct
Chile Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017 Summary ”Chile Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by ...

Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections by GlobalData
Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections Summary GlobalData’s new report, ...

Latin American Markets for Facial Injectables 2011 by Millennium Research Group
Introduction: The Latin American facial injectables market—comprising sales of botulinum toxin (BTX), hyaluronic acid (HA) dermal fillers, and particle and polymer fillers (PPFs) for cosmetic ...

Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Systems, Infusion Systems and Others by GlobalData
Drug Delivery Devices Market Outlook in Argentina to 2016 - Inhalation Systems, Infusion Systems and Others Summary GlobalData’s medical device report, “Drug Delivery Devices Market Outlook in ...

BRIC Diabetes Drugs Market by MarketsandMarkets
The prevalence of diabetes is on the rise across the globe due to increased life expectancy, changing lifestyles, and the rising incidence of obesity. Brazil’s ...

See all reports like this >>

More South America Reports

Homewares in Brazil by Euromonitor International
The performance of homewares has been driven by the growing number of new dwellings, especially in metropolitan cities, as well as increasing disposable income, mainly ...

D&B Country RiskLine Report: Venezuela by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Uruguay by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Peru by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Paraguay by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

See all reports like this >>

South and Central America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Share this report

Other tasks

Research Assistance

Related Markets

Drug Delivery Reports

Free Alert Me service